Researchers tracked data from nearly 8,000 patients evaluated with Heartflow's FDA-cleared Plaque Analysis software. Overall, the technology's Plaque Staging feature was found to provide significant value during the diagnosis and management of these patients.
The new drug from Merck was linked to several benefits for patients who are already on statins. If an oral PCSK9 inhibitor gains FDA approval, it could be a game-changer for the field of preventive medicine.
Reducing total calorie intake and minimizing large meals, on the other hand, were both linked to improved weight loss. The study followed participants for an average of 6.3 years.
Accelerated MRI with AI image reconstruction nearly halved orthopedic scan times while maintaining or even improving image quality in a newly published prospective study.
Peter Libby, MD, a cardiovascular medicine specialist with Brigham and Women’s Hospital and Harvard Medical School, explained some key takeaways from the PROMINENT trial.
Thanks to functional MRI exams, experts recently gained new insight into mechanisms behind the “loosening of associations” commonly observed in individuals diagnosed with schizophrenia.
Primary aldosteronism (PA) is one the single most common causes of hypertension, but identifying patients with PA—and knowing which ones may benefit from a surgical treatment—can be quite challenging.
The 10-minute scan can “light up” aldosterone-producing nodules in the adrenal glands following an injection of metomidate—a radioactive dye that binds specifically to aldosterone-producing nodules.
